Literature DB >> 33628950

Ascertaining and classifying cases of congenital anomalies in the ALSPAC birth cohort.

Kurt Taylor1,2, Richard Thomas1,3, Mark Mumme3, Jean Golding1,4, Andy Boyd1,3, Kate Northstone1,3, Massimo Caputo5,6, Deborah A Lawlor1,2,6.   

Abstract

Congenital anomalies (CAs) are structural or functional disorders that occur during intrauterine life. Longitudinal cohort studies provide unique opportunities to investigate potential causes and consequences of these disorders. In this data note, we describe how we identified cases of major CAs, with a specific focus on congenital heart diseases (CHDs), in the Avon Longitudinal Study of Parents and Children (ALSPAC). We demonstrate that combining multiple sources of data including data from antenatal, delivery, primary and secondary health records, and parent-reported information can improve case ascertainment. Our approach identified 590 participants with a CA according to the European Surveillance of Congenital Anomalies (EUROCAT) guidelines, 127 of whom had a CHD. We describe the methods that identified these cases and provide statistics on subtypes of anomalies. The data note contains details on the processes required for researchers to access these data. Copyright:
© 2021 Taylor K et al.

Entities:  

Keywords:  ALSPAC; birth cohort; congenital anomaly; congenital heart disease; longitudinal cohort; record linkage

Year:  2021        PMID: 33628950      PMCID: PMC7871361.2          DOI: 10.12688/wellcomeopenres.16339.2

Source DB:  PubMed          Journal:  Wellcome Open Res        ISSN: 2398-502X


  23 in total

1.  A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.

Authors:  K North; J Golding
Journal:  BJU Int       Date:  2000-01       Impact factor: 5.588

2.  Risk factors for congenital anomaly in a multiethnic birth cohort: an analysis of the Born in Bradford study.

Authors:  Eamonn Sheridan; John Wright; Neil Small; Peter C Corry; Sam Oddie; Catherine Whibley; Emily S Petherick; Teena Malik; Nicole Pawson; Patricia A McKinney; Roger C Parslow
Journal:  Lancet       Date:  2013-07-04       Impact factor: 79.321

3.  Intake of sucrose-sweetened soft beverages during pregnancy and risk of congenital heart defects (CHD) in offspring: a Norwegian pregnancy cohort study.

Authors:  Maria T Grønning Dale; Per Magnus; Elisabeth Leirgul; Henrik Holmstrøm; Håkon K Gjessing; Kristoffer Brodwall; Margaretha Haugen; Camilla Stoltenberg; Nina Øyen
Journal:  Eur J Epidemiol       Date:  2019-01-19       Impact factor: 8.082

4.  Ascertaining and classifying cases of congenital anomalies in the ALSPAC birth cohort.

Authors:  Kurt Taylor; Richard Thomas; Mark Mumme; Jean Golding; Andy Boyd; Kate Northstone; Massimo Caputo; Deborah A Lawlor
Journal:  Wellcome Open Res       Date:  2021-04-14

5.  Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort.

Authors:  Abigail Fraser; Corrie Macdonald-Wallis; Kate Tilling; Andy Boyd; Jean Golding; George Davey Smith; John Henderson; John Macleod; Lynn Molloy; Andy Ness; Susan Ring; Scott M Nelson; Debbie A Lawlor
Journal:  Int J Epidemiol       Date:  2012-04-16       Impact factor: 7.196

6.  Cohort Profile: the 'children of the 90s'--the index offspring of the Avon Longitudinal Study of Parents and Children.

Authors:  Andy Boyd; Jean Golding; John Macleod; Debbie A Lawlor; Abigail Fraser; John Henderson; Lynn Molloy; Andy Ness; Susan Ring; George Davey Smith
Journal:  Int J Epidemiol       Date:  2012-04-16       Impact factor: 7.196

7.  Defining adolescent common mental disorders using electronic primary care data: a comparison with outcomes measured using the CIS-R.

Authors:  Rosie P Cornish; Ann John; Andy Boyd; Kate Tilling; John Macleod
Journal:  BMJ Open       Date:  2016-12-01       Impact factor: 2.692

8.  The incidentally diagnosed adult congenital heart disease during routine medical health checkups in 27,897 Koreans at a single center over seven years.

Authors:  Eun Min Kwag; Ju Suk Lee; Sung Hoon Kim
Journal:  BMC Cardiovasc Disord       Date:  2018-12-05       Impact factor: 2.298

9.  Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies.

Authors:  Yingjuan Liu; Sen Chen; Liesl Zühlke; Graeme C Black; Mun-Kit Choy; Ningxiu Li; Bernard D Keavney
Journal:  Int J Epidemiol       Date:  2019-04-01       Impact factor: 7.196

10.  Factors associated with participation over time in the Avon Longitudinal Study of Parents and Children: a study using linked education and primary care data.

Authors:  Rosie P Cornish; John Macleod; Andy Boyd; Kate Tilling
Journal:  Int J Epidemiol       Date:  2021-03-03       Impact factor: 7.196

View more
  3 in total

1.  Ascertaining and classifying cases of congenital anomalies in the ALSPAC birth cohort.

Authors:  Kurt Taylor; Richard Thomas; Mark Mumme; Jean Golding; Andy Boyd; Kate Northstone; Massimo Caputo; Deborah A Lawlor
Journal:  Wellcome Open Res       Date:  2021-04-14

2.  The Relationship of Maternal Gestational Mass Spectrometry-Derived Metabolites with Offspring Congenital Heart Disease: Results from Multivariable and Mendelian Randomization Analyses.

Authors:  Kurt Taylor; Nancy McBride; Jian Zhao; Sam Oddie; Rafaq Azad; John Wright; Ole A Andreassen; Isobel D Stewart; Claudia Langenberg; Maria Christine Magnus; Maria Carolina Borges; Massimo Caputo; Deborah A Lawlor
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-27

3.  Effect of Maternal Prepregnancy/Early-Pregnancy Body Mass Index and Pregnancy Smoking and Alcohol on Congenital Heart Diseases: A Parental Negative Control Study.

Authors:  Kurt Taylor; Ahmed Elhakeem; Johanna Lucia Thorbjørnsrud Nader; Tiffany C Yang; Elena Isaevska; Lorenzo Richiardi; Tanja Vrijkotte; Angela Pinot de Moira; Deirdre M Murray; Daragh Finn; Dan Mason; John Wright; Sam Oddie; Nel Roeleveld; Jennifer R Harris; Anne-Marie Nybo Andersen; Massimo Caputo; Deborah A Lawlor
Journal:  J Am Heart Assoc       Date:  2021-05-27       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.